FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288748468> ?p ?o ?g. }

• W4288748468 abstract "Congenital disorders of glycosylation (CDG) are a large family of rare genetic diseases for which therapies are virtually nonexistent. However, CDG therapeutic research has been expanding, thanks to the continuous efforts of the CDG medical/scientific and patient communities. Hence, CDG drug development is a popular research topic. The main aim of this study was to understand current and steer future CDG drug development and approval by collecting and analysing the views and experiences of the CDG community, encompassing professionals and families. An electronic (e-)survey was developed and distributed to achieve this goal.A total of 128 respondents (46 CDG professionals and 82 family members), mainly from Europe and the USA, participated in this study. Most professionals (95.0%) were relatively familiar with drug development and approval processes, while CDG families revealed low familiarity levels, with 8.5% admitting to never having heard about drug development. However, both stakeholder groups agreed that patients and families make significant contributions to drug development and approval. Regarding their perceptions of and experiences with specific drug development and approval tools, namely biobanks, disease models, patient registries, natural history studies (NHS) and clinical trials (CT), the CDG community stakeholders described low use and participation, as well as variable familiarity. Additionally, CDG professionals and families shared conflicting views about CT patient engagement and related information sharing. Families reported lower levels of involvement in CT design (25.0% declared ever being involved) and information (60.0% stated having been informed) compared to professionals (60.0% and 85.7%, respectively). These contrasting perceptions were further extended to their insights and experiences with patient-centric research. Finally, the CDG community (67.4% of professionals and 54.0% of families) reported a positive vision of artificial intelligence (AI) as a drug development tool. Nevertheless, despite the high AI awareness among CDG families (76.8%), professionals described limited AI use in their research (23.9%).This community-centric study sheds new light on CDG drug development and approval. It identifies educational, communication and research gaps and opportunities for CDG professionals and families that could improve and accelerate CDG therapy development." @default.
• W4288748468 created "2022-07-30" @default.
• W4288748468 creator A5020022294 @default.
• W4288748468 creator A5023750294 @default.
• W4288748468 creator A5037922892 @default.
• W4288748468 creator A5064309231 @default.
• W4288748468 creator A5074303150 @default.
• W4288748468 creator A5085357042 @default.
• W4288748468 creator A5085627974 @default.
• W4288748468 creator A5085765615 @default.
• W4288748468 creator A5090457672 @default.
• W4288748468 date "2022-07-30" @default.
• W4288748468 modified "2023-10-14" @default.
• W4288748468 title "Stakeholders’ views on drug development: the congenital disorders of glycosylation community perspective" @default.
• W4288748468 cites W1963729574 @default.
• W4288748468 cites W1964873592 @default.
• W4288748468 cites W1983336438 @default.
• W4288748468 cites W1991041813 @default.
• W4288748468 cites W2022854814 @default.
• W4288748468 cites W2023648770 @default.
• W4288748468 cites W2050230588 @default.
• W4288748468 cites W2072737229 @default.
• W4288748468 cites W2087562988 @default.
• W4288748468 cites W2123053428 @default.
• W4288748468 cites W2148050774 @default.
• W4288748468 cites W2160077846 @default.
• W4288748468 cites W2170128118 @default.
• W4288748468 cites W2473960300 @default.
• W4288748468 cites W2528157651 @default.
• W4288748468 cites W2579037847 @default.
• W4288748468 cites W2601384930 @default.
• W4288748468 cites W2602238011 @default.
• W4288748468 cites W2607198221 @default.
• W4288748468 cites W2610665417 @default.
• W4288748468 cites W2612814229 @default.
• W4288748468 cites W2759862759 @default.
• W4288748468 cites W2766176933 @default.
• W4288748468 cites W2774641259 @default.
• W4288748468 cites W2775259680 @default.
• W4288748468 cites W2777648031 @default.
• W4288748468 cites W2785583877 @default.
• W4288748468 cites W2788076582 @default.
• W4288748468 cites W2800620664 @default.
• W4288748468 cites W2804083262 @default.
• W4288748468 cites W2808484157 @default.
• W4288748468 cites W2883405123 @default.
• W4288748468 cites W2884890424 @default.
• W4288748468 cites W2891828871 @default.
• W4288748468 cites W2899710525 @default.
• W4288748468 cites W2961792602 @default.
• W4288748468 cites W2969488578 @default.
• W4288748468 cites W2970921286 @default.
• W4288748468 cites W2971106123 @default.
• W4288748468 cites W2989824398 @default.
• W4288748468 cites W2998937058 @default.
• W4288748468 cites W3012526509 @default.
• W4288748468 cites W3039377240 @default.
• W4288748468 cites W3044837247 @default.
• W4288748468 cites W3089691710 @default.
• W4288748468 cites W3111099682 @default.
• W4288748468 cites W3119992351 @default.
• W4288748468 cites W3189109230 @default.
• W4288748468 cites W3199484946 @default.
• W4288748468 cites W4200548613 @default.
• W4288748468 doi "https://doi.org/10.1186/s13023-022-02460-0" @default.
• W4288748468 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35907899" @default.
• W4288748468 hasPublicationYear "2022" @default.
• W4288748468 type Work @default.
• W4288748468 citedByCount "4" @default.
• W4288748468 countsByYear W42887484682022 @default.
• W4288748468 countsByYear W42887484682023 @default.
• W4288748468 crossrefType "journal-article" @default.
• W4288748468 hasAuthorship W4288748468A5020022294 @default.
• W4288748468 hasAuthorship W4288748468A5023750294 @default.
• W4288748468 hasAuthorship W4288748468A5037922892 @default.
• W4288748468 hasAuthorship W4288748468A5064309231 @default.
• W4288748468 hasAuthorship W4288748468A5074303150 @default.
• W4288748468 hasAuthorship W4288748468A5085357042 @default.
• W4288748468 hasAuthorship W4288748468A5085627974 @default.
• W4288748468 hasAuthorship W4288748468A5085765615 @default.
• W4288748468 hasAuthorship W4288748468A5090457672 @default.
• W4288748468 hasBestOaLocation W42887484681 @default.
• W4288748468 hasConcept C116567970 @default.
• W4288748468 hasConcept C118552586 @default.
• W4288748468 hasConcept C17744445 @default.
• W4288748468 hasConcept C201305675 @default.
• W4288748468 hasConcept C2780035454 @default.
• W4288748468 hasConcept C39549134 @default.
• W4288748468 hasConcept C512399662 @default.
• W4288748468 hasConcept C60644358 @default.
• W4288748468 hasConcept C64903051 @default.
• W4288748468 hasConcept C71924100 @default.
• W4288748468 hasConcept C86803240 @default.
• W4288748468 hasConceptScore W4288748468C116567970 @default.
• W4288748468 hasConceptScore W4288748468C118552586 @default.
• W4288748468 hasConceptScore W4288748468C17744445 @default.
• W4288748468 hasConceptScore W4288748468C201305675 @default.
• W4288748468 hasConceptScore W4288748468C2780035454 @default.
• W4288748468 hasConceptScore W4288748468C39549134 @default.
• W4288748468 hasConceptScore W4288748468C512399662 @default.

• next